Here's How Much a $1000 Investment in Eli Lilly Made 10 Years Ago Would Be Worth Today
https://www.zacks.com/stock/news/2291308/here-s-how-much-a-1000-investment-in-eli-lilly-made-10-years-ago-would-be-worth-today?cid=CS-ZC-FT-tale_of_the_tape|investing_$1000-2291308
Jun 21, 2024 - Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
0
Eli Lilly Has a New Drug That Could Push the Stock Higher
https://www.fool.com/investing/2024/06/20/eli-lilly-has-a-new-drug-that-could-push-the-stock/?source=iedfolrf0000001
Jun 20, 2024 - The Alzheimer’s treatment market is large and expected to grow.
0
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
https://www.zacks.com/stock/news/2290782/here-s-why-eli-lilly-lly-is-probably-the-best-drug-stock-now?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2290782
Jun 20, 2024 - Eli Lilly (LLY) enjoys strong fundamentals and is expected to consistently do well, mainly supported by its new drugs and its solid pipeline.
0
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
https://www.cnbc.com/2024/06/17/eli-lilly-cfo-anat-ashkenazi-on-managing-soaring-demand-for-glp-1s.html
Jun 17, 2024 - Ashkenazi has been key to managing the windfall in revenue and wave of investor optimism from Eli Lilly's diabetes injection Mounjaro and obesity drug Zepbound.
0
The Zacks Analyst Blog Highlights Berkshire Hathaway, Eli Lilly, PepsiCo, Hovnanian and IDT
https://www.zacks.com/stock/news/2289110/the-zacks-analyst-blog-highlights-berkshire-hathaway-eli-lilly-pepsico-hovnanian-and-idt?cid=CS-ZC-FT-press_releases-2289110
Jun 17, 2024 - Berkshire Hathaway, Eli Lilly, PepsiCo, Hovnanian and IDT are part of the Zacks top Analyst Blog.
0
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster
https://www.fool.com/investing/2024/06/15/eli-lilly-scores-another-major-win-and-lines-up-it/?source=iedfolrf0000001
Jun 15, 2024 - The drugmaker continues to make headlines for all the right reasons.
0
Top Stock Reports for Berkshire Hathaway, Eli Lilly & PepsiCo
https://www.zacks.com/commentary/2288461/top-stock-reports-for-berkshire-hathaway-eli-lilly-pepsico?cid=CS-ZC-FT-research_daily-2288461
Jun 14, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Eli Lilly and Company (LLY) and PepsiCo, Inc. (PEP), as well as two micro-cap stocks Hovnanian Enterprises, Inc. (HOV) and IDT Corporation (IDT).
0
Why Eli Lilly (LLY) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2287885/why-eli-lilly-lly-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2287885
Jun 13, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
https://www.cnbc.com/2024/06/10/fda-advisors-recommend-eli-lilly-alzheimers-drug-donanemab.html
Jun 10, 2024 - If approved, Eli Lilly's donanemab would become the second Alzheimer's drug of its kind currently on the U.S. market after Leqembi from Biogen and Eisai.
0
Eli Lilly (LLY) Veteran Anat Ashkenazi to Join Alphabet as CFO
https://www.zacks.com/stock/news/2284718/eli-lilly-lly-veteran-anat-ashkenazi-to-join-alphabet-as-cfo?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2284718
Jun 06, 2024 - Eli Lilly (LLY) CFO Anat Ashkenazi joins Google's parent company Alphabet as CFO and senior vice president, effective from Jul 31, 2024
0